News
Researchers at Yale School of Medicine have determined that a panel of biomarkers can help physicians better understand ...
A new study of more than 13 million people in England has found no evidence to suggest mild COVID-19 infection may cause long ...
Herbal supplements, despite their perceived natural safety, pose significant risks to liver and kidney health due to ...
11h
News Medical on MSNStudy finds no evidence to suggest mild COVID-19 may cause long-term kidney damageA new study of over 13 million people in England has found no evidence to suggest mild COVID-19 infection may cause long-term ...
Dr. Sanjib Kumar Sharma serves as the Acting Vice-Chancellor as well as Rector at BP Koirala Institute of Health Sciences (BPKIHS), Dharan, Nepal.
13h
Nigerian Tribune on MSNFrom overburdened specialist hospital to avant-garde tertiary medical centreBy Adewale Ajibuwa A few years ago, the National Universities Commission (NUC) granted formal approval to the Federal ...
Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, proudly announces the initial US launch ...
Dr. Michael Serzan explains the importance of clinical trial enrollment for patients with kidney cancer and highlighted findings from the STELLA-002 trial.
Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.
Panelists discuss how minimal residual disease (MRD) status can guide post-transplant treatment decisions, particularly for high-risk patients who don’t achieve MRD negativity and patients considering ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results